FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

631011000001107: Dostinex 500microgram tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16648901000001117 Dostinex 500microgram tablets (Pfizer Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16649001000001110 Dostinex 500microgram tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dostinex 500microgram tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Is a Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Is a Dostinex true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Is pack of False Dostinex 500microgram tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has AMP True Dostinex 500microgram tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start